RankAlpha logo
Back to Rankings

ESLA

Estrella ImmunopharmaF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
ESLA vs peer average
44/100
ESLA vs. peer average (F vs. F)
Grade spread
B 1 · F 7
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

LITS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $35.05M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerLITSLite Strategy
ESLA
Estrella Immunopharma
LITS
Lite Strategy
Grade
F
F
Momentum
28
20
Value
41
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs LITS

ESLA / LITS
Grade Position
Below peers
ESLA vs. peer average (F vs. F)
44/100
Momentum
28
ESLA
Value
41
ESLA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ESLA
1
LITS
Lite Strategy Inc Common
F
20/100
Even
2
VYNE
VYNE Therapeutics Inc Common
F
20/100
Even
3
VERU
Veru Inc Common
F
20/100
Even
4
GNTA
Genenta Science SpA ADR
F
20/100
Even
5
NTRB
Nutriband Inc Common
B
80/100
-3
LITS is the first peer returned for this comparison set.